However, in some patients, it can also have more serious side effects such as inflammation of the pancreas, kidney failure, changes in vision in diabetics, and even possible development of thyroid tumors. In general, Wegovy is a safe drug that causes mild side effects such as headache, nausea, vomiting, diarrhea, or constipation. A holistic approach is necessary to treat obesity, and this must be emphasized by healthcare workers that are treating patients battling obesity. By providing a drug that not only decreases weight but also decreases one’s risk of heart disease and stroke, it is possible patients may not pay attention to the lifestyle changes such as diet and exercise that are critical to maintaining a healthy lifestyle. Obesity is a chronic medical disease that requires a multi-faceted approach that includes not only drug therapy, but also lifestyle changes, diet, exercise and coaching. Will This Trial Perpetuate The Notion Of Medicating Obesity As Oppose To Addressing Its Root Causes? Only time will tell to see if weight loss medications will finally become covered under Medicare and insurance companies. Insurance companies are going to want to cover it but they’re going to want to also see long term adherence.” Rekha Kumar, practicing endocrinologist, Chief Medical Officer at weight care program Found and former Medical Director of the American Board of Obesity Medicine, states, “The new trial will force the insurance industry to think more critically about the purpose of anti-obesity medication and to think of it beyond a vanity drug. Given the large health benefit this drug could provide in mitigating the leading cause of death in America, insurers may need to think twice before denying coverage.ĭr. Medicare and many insurers do not cover weight loss medications, and Wegovy can cost more than $1300 a month according to The New York Times. Will The Results Of The Trial Push Insurers To Cover The Drug? Some patients may have a family history of heart disease and would want to know what the exact effect of the drug would be on that outcome versus another outcome. For patients, it would be helpful to know if the drug was more beneficial at mitigating one outcome over another, say heart attack over stroke. The company stopped short at providing details for each individual outcome. Does Wegovy Have The Same Effect On Heart Attacks, Stroke, And Cardiovascular Disease?īased on Novo Nordisk’s announcement, Wegovy could decrease the overall risk of heart attack, stroke, and cardiovascular disease by 20%.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |